MDRNA Inks Second 'Early Collaborative Effort,' Releases Preclinical Cancer Data

According to the company, the collaboration will focus on in vivo delivery of siRNAs using the DiLA2 platform. Research teams at the companies "will examine safety and efficacy of systemic delivery of siRNA in animal models," MDRNA said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories